{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:33:49Z","timestamp":1791999229553,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11011-023-01274-8","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T06:02:29Z","timestamp":1693807349000},"page":"2563-2572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Expression analysis of inhibitory B7 family members in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-8357","authenticated-orcid":false,"given":"Hani","family":"Sabaie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0294-8722","authenticated-orcid":false,"given":"Parham","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2613-3421","authenticated-orcid":false,"given":"Jalal","family":"Gharesouran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0152-0661","authenticated-orcid":false,"given":"Zoha","family":"Salkhordeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7055-9550","authenticated-orcid":false,"given":"Mohammad Reza","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirmohsen","family":"Sharifi-Bonab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2071-1208","authenticated-orcid":false,"given":"Zeinab","family":"Shirvani-Farsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-0591","authenticated-orcid":false,"given":"Mohammad","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9417-6466","authenticated-orcid":false,"given":"Arezou","family":"Sayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0790-1317","authenticated-orcid":false,"given":"Maryam","family":"Rezazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"1274_CR1","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/ijms22052652","volume":"22","author":"NK Ahangar","year":"2021","unstructured":"Ahangar NK, Hemmat N, Khalaj-Kondori M, Shadbad MA, Sabaie H, Mokhtarzadeh A, Alizadeh N, Derakhshani A, Baghbanzadeh A, Dolatkhah K, Silvestris N, Baradaran B (2021) The Regulatory Cross-Talk between microRNAs and Novel Members of the B7 Family in Human Diseases: a scoping review. Int J Mol Sci 22:2652","journal-title":"Int J Mol Sci"},{"key":"1274_CR2","unstructured":"Association AP (2013) Diagnostic and statistical manual of mental disorders (5th ed.)"},{"key":"1274_CR3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer\u2019s disease. Lancet 377:1019\u20131031","journal-title":"Lancet"},{"key":"1274_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8967","volume":"6","author":"K Baruch","year":"2015","unstructured":"Baruch K, Rosenzweig N, Kertser A, Deczkowska A, Sharif AM, Spinrad A, Tsitsou-Kampeli A, Sarel A, Cahalon L, Schwartz M (2015) Breaking immune tolerance by targeting Foxp3 + regulatory T cells mitigates Alzheimer\u2019s disease pathology. Nat Commun 6:1\u201312","journal-title":"Nat Commun"},{"key":"1274_CR4","doi-asserted-by":"crossref","unstructured":"Baruch K, Deczkowska A, Rosenzweig N, Tsitsou-Kampeli A, Sharif A, Matcovitch O, Kertser A, David E, Amit I, Schwartz M (2016) PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease. Nat Med, 22","DOI":"10.1038\/nm.4022"},{"key":"1274_CR6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","volume":"17","author":"BM Bettcher","year":"2021","unstructured":"Bettcher BM, Tansey MG, Doroth\u00e9e G, Heneka MT (2021) Peripheral and central immune system crosstalk in Alzheimer disease \u2014 a research prospectus. Nat Reviews Neurol 17:689\u2013701","journal-title":"Nat Reviews Neurol"},{"key":"1274_CR7","doi-asserted-by":"crossref","unstructured":"Bolandi N, Derakhshani A, Hemmat N, Baghbanzadeh A, Asadzadeh Z, Afrashteh Nour M, Brunetti O, Bernardini R, Silvestris N, Baradaran B (2021) The positive and negative Immunoregulatory Role of B7 Family: promising novel targets in gastric Cancer treatment. Int J Mol Sci, 22","DOI":"10.3390\/ijms221910719"},{"key":"1274_CR8","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/glia.23517","volume":"66","author":"M Borggrewe","year":"2018","unstructured":"Borggrewe M, Grit C, Dunnen D, Burm WFA, Bajramovic SM, Noelle JJ, Eggen RJ, B. J. L., Laman JD (2018) VISTA expression by microglia decreases during inflammation and is differentially regulated in CNS diseases. Glia 66:2645\u20132658","journal-title":"Glia"},{"key":"1274_CR9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-150217","volume":"47","author":"S Busse","year":"2015","unstructured":"Busse S, Steiner J, Alter J, Dobrowolny H, Mawrin C, Bogerts B, Hartig R, Busse M (2015) Expression of HLA-DR, CD80, and CD86 in Healthy Aging and Alzheimer\u2019s Disease. J Alzheimers Dis 47:177\u2013184","journal-title":"J Alzheimers Dis"},{"key":"1274_CR10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9","volume":"32","author":"LL Carter","year":"2002","unstructured":"Carter LL, Fouser LA, Jussif J, Fitz L, Deng B, Wood CR, Collins M, Honjo T, Freeman GJ, Carreno BM (2002) PD-1: PD\u2010L inhibitory pathway affects both CD4 + and CD8 + T cells and is overcome by IL\u20102. Eur J Immunol 32:634\u2013643","journal-title":"Eur J Immunol"},{"key":"1274_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2016.12.001","volume":"73","author":"S Cuzzubbo","year":"2017","unstructured":"Cuzzubbo S, Javeri F, Tissier M, Roumi A, Barlog C, Doridam J, Lebbe C, Belin C, Ursu R, Carpentier AF (2017) Neurological adverse events associated with immune checkpoint inhibitors: review of the literature. Eur J Cancer 73:1\u20138","journal-title":"Eur J Cancer"},{"key":"1274_CR12","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.jalz.2018.02.014","volume":"14","author":"SK Darweesh","year":"2018","unstructured":"Darweesh SK, Wolters FJ, Ikram MA, De Wolf F, Bos D, Hofman A (2018) Inflammatory markers and the risk of dementia and Alzheimer\u2019s disease: a meta-analysis. Alzheimer\u2019s Dement 14:1450\u20131459","journal-title":"Alzheimer\u2019s Dement"},{"key":"1274_CR13","doi-asserted-by":"crossref","first-page":"e1000137","DOI":"10.1371\/journal.pgen.1000137","volume":"4","author":"M Dokmanovic-Chouinard","year":"2008","unstructured":"Dokmanovic-Chouinard M, Chung WK, Chevre JC, Watson E, Yonan J, Wiegand B, Bromberg Y, Wakae N, Wright CV, Overton J, Ghosh S, Sathe GM, Ammala CE, Brown KK, Leduc ITOR, Solomon C, Fischer K, S. G., Leibel RL (2008) Positional cloning of \u201cLisch-Like\u201d, a candidate modifier of susceptibility to type 2 diabetes in mice. PLoS Genet 4:e1000137","journal-title":"PLoS Genet"},{"key":"1274_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-015-1516-y","volume":"131","author":"YS Eisele","year":"2016","unstructured":"Eisele YS, Duyckaerts C (2016) Propagation of A\u00df pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:5\u201325","journal-title":"Acta Neuropathol"},{"key":"1274_CR15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","volume":"61","author":"MJ Engelhart","year":"2004","unstructured":"Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, Van Swieten JC, Stijnen T, Hofman A, Witteman JC, Breteler MM (2004) Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol 61:668\u2013672","journal-title":"Arch Neurol"},{"key":"1274_CR16","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3389\/fneur.2019.01312","volume":"10","author":"L Fan","year":"2019","unstructured":"Fan L, Mao C, Hu X, Zhang S, Yang Z, Hu Z, Sun H, Fan Y, Dong Y, Shi YANGJ, C., Xu Y (2019) New Insights into the pathogenesis of Alzheimer\u2019s Disease. Front Neurol 10:1312","journal-title":"Front Neurol"},{"key":"1274_CR17","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ni.1790","volume":"10","author":"BT Fife","year":"2009","unstructured":"Fife BT, Pauken KE, Eagar TN, Obu T, Wu J, Tang Q, Azuma M, Krummel MF, Bluestone JA (2009) Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR\u2013induced stop signal. Nat Immunol 10:1185\u20131192","journal-title":"Nat Immunol"},{"key":"1274_CR18","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1172\/JCI74589","volume":"124","author":"DB Flies","year":"2014","unstructured":"Flies DB, Han X, Higuchi T, Zheng L, Sun J, Ye JJ, Chen L (2014) Coinhibitory receptor PD-1H preferentially suppresses CD4+ T cell-mediated immunity. J Clin Invest 124:1966\u20131975","journal-title":"J Clin Invest"},{"key":"1274_CR19","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","volume":"192","author":"GJ Freeman","year":"2000","unstructured":"Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC (2000a) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192:1027\u20131034","journal-title":"J Exp Med"},{"key":"1274_CR20","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","volume":"192","author":"GJ Freeman","year":"2000","unstructured":"Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, Horton HF, Fouser L, Carter L, Ling V, Bowman MR, Carreno BM, Collins M, Wood CR, Honjo T (2000b) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192:1027\u20131034","journal-title":"J Exp Med"},{"key":"1274_CR21","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1172\/JCI31344","volume":"117","author":"I Gotsman","year":"2007","unstructured":"Gotsman I, Grabie N, Dacosta R, Sukhova G, Sharpe A, Lichtman AH (2007) Proatherogenic immune responses are regulated by the PD-1\/PD-L pathway in mice. J Clin Investig 117:2974\u20132982","journal-title":"J Clin Investig"},{"key":"1274_CR22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356","journal-title":"Science"},{"key":"1274_CR23","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.4049\/jimmunol.1700325","volume":"200","author":"I Hecht","year":"2018","unstructured":"Hecht I, Toporik A, Podojil JR, Vaknin I, Cojocaru G, Oren A, Aizman E, Liang SC, Leung L, Dicken Y, Novik A, Marbach-Bar N, Elmesmari A, Tange C, Gilmour A, Mcintyre D, Kurowska-Stolarska M, Mcnamee K, Leitner J, Greenwald S, Dassa L, Levine Z, Steinberger P, Williams RO, Miller SD, Mcinnes IB, Neria E, Rotman G (2018) ILDR2 is a novel B7-like protein that negatively regulates T cell responses. J Immunol 200:2025\u20132037","journal-title":"J Immunol"},{"key":"1274_CR24","doi-asserted-by":"crossref","unstructured":"Huang L-T, Zhang C-P, Wang Y-B, Wang J-H (2022) Association of Peripheral Blood Cell Profile With Alzheimer\u2019s Disease: A Meta-Analysis. Front Aging Neurosci, 14","DOI":"10.3389\/fnagi.2022.888946"},{"key":"1274_CR25","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1158\/1078-0432.CCR-14-1495","volume":"21","author":"M Janakiram","year":"2015","unstructured":"Janakiram M, chinai JM, fineberg S, fiser A, montagna C, medavarapu R, castano E, jeon H, ohaegbulam KC, zhao R, zhao A, almo SC, sparano JA, zang X (2015) Expression, clinical significance, and receptor identification of the newest B7 family Member HHLA2 protein. Clin Cancer Res 21:2359\u20132366","journal-title":"Clin Cancer Res"},{"key":"1274_CR26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-065X.2012.01136.x","volume":"248","author":"N Joller","year":"2012","unstructured":"Joller N, Peters A, Anderson AC, Kuchroo VK (2012) Immune checkpoints in central nervous system autoimmunity. Immunol Rev 248:122\u2013139","journal-title":"Immunol Rev"},{"key":"1274_CR27","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s12276-020-00494-7","volume":"52","author":"SS Kang","year":"2020","unstructured":"Kang SS, Ahn EH, Ye K (2020) Delta-secretase cleavage of tau mediates its pathology and propagation in Alzheimer\u2019s disease. Exp Mol Med 52:1275\u20131287","journal-title":"Exp Mol Med"},{"key":"1274_CR28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/emmm.201100165","volume":"3","author":"K Karwacz","year":"2011","unstructured":"Karwacz K, Bricogne C, Macdonald D, Arce F, Bennett CL, Collins M, Escors D (2011) PD-L1 co\u2010stimulation contributes to ligand\u2010induced T cell receptor down\u2010modulation on CD8 + T cells. EMBO Mol Med 3:581\u2013592","journal-title":"EMBO Mol Med"},{"key":"1274_CR29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, LAMB BT (2018) Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement (N Y) 4:575\u2013590","journal-title":"Alzheimers Dement (N Y)"},{"key":"1274_CR30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/gerona\/gls187","volume":"68","author":"A Koyama","year":"2013","unstructured":"Koyama A, O\u2019brien J, Weuve J, Blacker D, Metti AL, Yaffe K (2013) The role of peripheral inflammatory markers in dementia and Alzheimer\u2019s disease: a meta-analysis. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences 68:433\u2013440","journal-title":"Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences"},{"key":"1274_CR31","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jnnp-2017-316201","volume":"88","author":"KSP Lai","year":"2017","unstructured":"Lai KSP, Liu CS, Rau A, Lanct\u00f4t KL, K\u00f6hler CA, Pakosh M, Carvalho AF, Herrmann N (2017) Peripheral inflammatory markers in Alzheimer\u2019s disease: a systematic review and meta-analysis of 175 studies. J Neurol Neurosurg Psychiatry 88:876\u2013882","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1274_CR32","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1158\/0008-5472.CAN-13-1506","volume":"74","author":"I Le Mercier","year":"2014","unstructured":"Le Mercier I, Chen W, Lines JL, Day M, Sergent LIJ, Noelle P, R. J., Wang L (2014) VISTA regulates the development of Protective Antitumor Immunity. Cancer Res 74:1933\u20131944","journal-title":"Cancer Res"},{"key":"1274_CR33","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1158\/1535-7163.MCT-11-0072","volume":"10","author":"H Liu","year":"2011","unstructured":"Liu H, Tekle C, Chen YW, Kristian A, Zhao Y, Zhou M, Liu Z, Ding Y, Wang B, M\u00e6landsmo GM, Nesland JM, Fodstad O, Tan M (2011) B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2\/Stat3 phosphorylation. Mol Cancer Ther 10:960\u2013971","journal-title":"Mol Cancer Ther"},{"key":"1274_CR34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12974-021-02320-x","volume":"18","author":"H Liu","year":"2021","unstructured":"Liu H, Zhao J, Lin Y, Su M, Lai L (2021) Administration of anti-ERMAP antibody ameliorates Alzheimer\u2019s disease in mice. J Neuroinflammation 18:268","journal-title":"J Neuroinflammation"},{"key":"1274_CR35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/imr.12525","volume":"276","author":"EC Nowak","year":"2017","unstructured":"Nowak EC, Lines JL, Varn FS, Deng J, Sarde A, Mabaera R, Kuta A, Mercier LE, Cheng I, C., Noelle RJ (2017) Immunoregulatory functions of VISTA. Immunol Rev 276:66\u201379","journal-title":"Immunol Rev"},{"key":"1274_CR36","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1074-7613(03)00147-X","volume":"18","author":"DV Prasad","year":"2003","unstructured":"Prasad DV, Richards S, Mai XM, Dong C (2003) B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 18:863\u2013873","journal-title":"Immunity"},{"key":"1274_CR37","doi-asserted-by":"crossref","first-page":"16873","DOI":"10.1002\/jcp.28372","volume":"234","author":"M Rezazadeh","year":"2019","unstructured":"Rezazadeh M, Hosseinzadeh H, Moradi M, Salek Esfahani B, Talebian S, Parvin S, Gharesouran J (2019) Genetic discoveries and advances in late-onset Alzheimer\u2019s disease. J Cell Physiol 234:16873\u201316884","journal-title":"J Cell Physiol"},{"key":"1274_CR38","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1600-6143.2011.03451.x","volume":"11","author":"LV Riella","year":"2011","unstructured":"Riella LV, Watanabe T, Sage PT, Yang J, Yeung M, Azzi J, Vanguri V, Chandraker A, Sharpe AH, Sayegh MH, Najafian N (2011) Essential role of PDL1 expression on nonhematopoietic donor cells in acquired tolerance to vascularized cardiac allografts. Am J Transplant 11:832\u2013840","journal-title":"Am J Transplant"},{"key":"1274_CR39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.10265","volume":"52","author":"R Schmidt","year":"2002","unstructured":"Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ (2002) Early inflammation and dementia: a 25-year follow\u2010up of the Honolulu\u2010Asia Aging Study. Ann Neurol 52:168\u2013174","journal-title":"Ann Neurol"},{"key":"1274_CR40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/YCO.0b013e32835a5947","volume":"26","author":"B Schneider","year":"2013","unstructured":"Schneider B, Prvulovic D (2013) Novel biomarkers in major depression. Curr Opin Psychiatry 26:47\u201353","journal-title":"Curr Opin Psychiatry"},{"key":"1274_CR41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.31887\/DCNS.2019.21.1\/mschwartz","volume":"21","author":"M Schwartz","year":"2019","unstructured":"Schwartz M, Arad M, Ben-Yehuda H (2019) Potential immunotherapy for Alzheimer disease and age-related dementia. Dialog Clin Neurosci 21:21\u201325","journal-title":"Dialog Clin Neurosci"},{"key":"1274_CR42","doi-asserted-by":"crossref","unstructured":"Sedy JR, Gavrieli M, Potter KG, Hurchla MA, Lindsley RC, Hildner K, Scheu S, Pfeffer K, Ware CF, Murphy TL, Murphy KM 2005. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol, 6, 90\u201398","DOI":"10.1038\/ni1144"},{"key":"1274_CR43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1443","volume":"8","author":"AH Sharpe","year":"2007","unstructured":"Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ (2007) The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 8:239\u2013245","journal-title":"Nat Immunol"},{"key":"1274_CR44","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1074-7613(03)00152-3","volume":"18","author":"GL Sica","year":"2003","unstructured":"Sica GL, Choi IH, Zhu G, Tamada K, Wang SD, Tamura H, Chapoval AI, Flies DB, Bajorath J, Chen L (2003) B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18:849\u2013861","journal-title":"Immunity"},{"key":"1274_CR45","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager W, Lanct\u00f4t K, Rothenburg L, Wong A, Cappell J, Herrmann N (2010) A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol Psychiatry 68:930\u2013941","journal-title":"Biol Psychiatry"},{"key":"1274_CR46","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1212\/01.wnl.0000263217.36439.da","volume":"68","author":"Z Tan","year":"2007","unstructured":"Tan Z, Beiser A, Vasan R, Roubenoff R, Dinarello C, Harris T, Benjamin E, Au R, Kiel D, Wolf P (2007) Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology 68:1902\u20131908","journal-title":"Neurology"},{"key":"1274_CR47","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ni944","volume":"4","author":"N Watanabe","year":"2003","unstructured":"Watanabe N, Gavrieli M, Sedy JR, Yang J, Fallarino F, Loftin SK, Hurchla MA, Zimmerman N, Sim J, Zang X, Murphy TL, Russell JH, Allison JP, Murphy KM (2003) BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 4:670\u2013679","journal-title":"Nat Immunol"},{"key":"1274_CR48","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nri1843","volume":"6","author":"HL Weiner","year":"2006","unstructured":"Weiner HL, Frenkel D (2006) Immunology and immunotherapy of Alzheimer\u2019s disease. Nat Rev Immunol 6:404\u2013416","journal-title":"Nat Rev Immunol"},{"key":"1274_CR49","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrneurol.2017.144","volume":"13","author":"LM Yshii","year":"2017","unstructured":"Yshii LM, Hohlfeld R, Liblau RS (2017) Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives. Nat Rev Neurol 13:755\u2013763","journal-title":"Nat Rev Neurol"},{"key":"1274_CR50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13659-018-0177-7","volume":"8","author":"HF Zhu","year":"2018","unstructured":"Zhu HF, Li Y (2018) Small-molecule targets in Tumor Immunotherapy. Nat Prod Bioprospect 8:297\u2013301","journal-title":"Nat Prod Bioprospect"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-023-01274-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-023-01274-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-023-01274-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T08:14:18Z","timestamp":1700554458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-023-01274-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1274"],"URL":"https:\/\/doi.org\/10.1007\/s11011-023-01274-8","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"12 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent forms were obtained from all study participants. The study protocol was approved by the ethical committee of Tabriz University of Medical Sciences. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have nothing to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}